XIFAXAN (Carilion Materials Management)


Welcome to the PulseAid listing for the XIFAXAN drug offered from Carilion Materials Management. This Rifamycin Antibacterial [EPC],Rifamycins [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Carilion Materials Management
NON-PROPRIETARY NAME: rifaximin
SUBSTANCE NAME: RIFAXIMIN
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Rifamycin Antibacterial [EPC],Rifamycins [Chemical/Ingredient]
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2004-07-25
END MARKETING DATE: 0000-00-00


XIFAXAN HUMAN PRESCRIPTION DRUG Details:

Item DescriptionXIFAXAN from Carilion Materials Management
LABELER NAME: Carilion Materials Management
DEA SCHEDULE:
ACTIVE STRENGTH: 200(mg/1)
START MARKETING DATE: 2004-07-25
END MARKETING DATE: 0000-00-00
PRODUCT ID: 68151-4980_0d88990d-6f38-4813-ab36-9d859a3453d6
PRODUCT NDC: 68151-4980
APPLICATION NUMBER: NDA021361

Other RIFAXIMIN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Avera McKennan HospitalXIFAXAN
Cardinal HealthXIFAXAN
Carilion Materials ManagementXIFAXAN
Dispensing Solutions, Inc.XIFAXAN
Physicians Total Care, Inc.XIFAXAN
Salix Pharmaceuticals, Inc.XIFAXAN